IPEC publishes GDP Audit Guideline for Pharmaceutical Excipients
Recommendation
2-4 July 2025
Copenhagen, Denmark
Part of the ICH Q7 Training Courses 2025
Register now for ECA's GMP Newsletter
The IPEC Good Distribution Practice (GDP) Audit Guideline for Pharmaceutical Excipients has been revised and the new version has been published. The previous version was published in 2008. The original version goes back to 2000.
The new document is designed in a questionnaire format to assist in evaluating the practices and quality systems of distributors who sell, store or repackage pharmaceutical excipients or any combination thereof. The audit guideline should be considered as the audit tool used in the evaluation of excipient distributors' GDP compliance, in accordance with the current IPEC GDP Guideline for Pharmaceutical Excipients (2006), which describes these principles in detail
Source: IPEC Press Release
Here you will find the IPEC Good Distribution Practice (GDP) Audit Guideline for Pharmaceutical Excipients
You can download the word version of the Guide here
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates